Literature DB >> 18085344

Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases.

M Schiesser1, J W C Chen, G J Maddern, R T A Padbury.   

Abstract

BACKGROUND: Hepatic resection is the treatment of choice in patients with colorectal liver metastases. Perioperative morbidity is associated with decreased long-term survival in several cancers. The aim of this study was to assess the impact of perioperative morbidity and other prognostic factors on the outcome of patients undergoing liver resection for colorectal metastases.
METHODS: One hundred ninety seven patients undergoing liver resection with curative intent were investigated. The influence of prognostic factors, such as complications, tumor stage, margins, age, sex, number of lesions, transfusion, portal inflow obstruction, and era and type of resection, was assessed using univariate and multivariate analysis. Complications were graded using an objective surgical complication classification.
RESULTS: The 5-year survival rate was 38%, with a median follow up of 4.5 years. The disease-free survival rate at 5 years was 23%. The perioperative morbidity and mortality rates were 30 and 2.5%, respectively. The median survival of patients with perioperative complications was 3.2 years, compared to 4.4 years in those patients without complications (p < 0.01). For patients with positive resection margins, the median survival was 2.1 years, compared 4.4 years in patients with a margin (p = 0.019).
CONCLUSION: Perioperative morbidity and a positive resection margin had a negative impact on long-term survival in patients following liver resection for colorectal metastases.

Entities:  

Mesh:

Year:  2007        PMID: 18085344     DOI: 10.1007/s11605-007-0438-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

1.  Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.

Authors:  T Mynster; I J Christensen; F Moesgaard; H J Nielsen
Journal:  Br J Surg       Date:  2000-11       Impact factor: 6.939

2.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Authors:  Thomas J Howard; Joseph E Krug; Jian Yu; Nick J Zyromski; C Max Schmidt; Lewis E Jacobson; James A Madura; Eric A Wiebke; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

3.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

4.  The impact of advanced age on hepatic resection of colorectal liver metastases.

Authors:  Yasuhiko Nagano; Kazunori Nojiri; Kenichi Matsuo; Kuniya Tanaka; Shinji Togo; Hideyuki Ike; Hiroshi Shimada
Journal:  J Am Coll Surg       Date:  2005-10       Impact factor: 6.113

Review 5.  Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis.

Authors:  Henrik Petrowsky; Mithat Gonen; William Jarnagin; Matthias Lorenz; Ronald DeMatteo; Stefan Heinrich; Albrecht Encke; Leslie Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

6.  Anastomotic leakage after colorectal cancer surgery: a risk factor for recurrence and poor prognosis.

Authors:  S Fujita; T Teramoto; M Watanabe; S Kodaira; M Kitajima
Journal:  Jpn J Clin Oncol       Date:  1993-10       Impact factor: 3.019

7.  Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie.

Authors:  D Jaeck; P Bachellier; M Guiguet; K Boudjema; J C Vaillant; P Balladur; B Nordlinger
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

8.  Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy.

Authors:  Michelle L DeOliveira; Jordan M Winter; Markus Schafer; Steven C Cunningham; John L Cameron; Charles J Yeo; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

9.  Poor prognosis in esophageal cancer patients with postoperative complications.

Authors:  T Hirai; Y Yamashita; H Mukaida; M Kuwahara; H Inoue; T Toge
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

10.  Does repeated surgery improve the prognosis of colorectal liver metastases?

Authors:  Zenichi Morise; Atsushi Sugioka; Junko Fujita; Sojun Hoshimoto; Takazumi Kato; Akitake Hasumi; Takashi Suda; Hiromichi Negi; Yoshinobu Hattori; Harunobu Sato; Kotaro Maeda
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.267

View more
  23 in total

1.  Complications following liver resection for colorectal metastases do not impact on longterm outcome.

Authors:  Tony C Pang; Calista Spiro; Tim Ramacciotti; Julian Choi; Martin Drummond; Edmund Sweeney; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2014-08-26       Impact factor: 3.647

2.  Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.

Authors:  Andreas Andreou; Luca Viganò; Giuseppe Zimmitti; Daniel Seehofer; Martin Dreyer; Andreas Pascher; Marcus Bahra; Wenzel Schoening; Volker Schmitz; Peter C Thuss-Patience; Timm Denecke; Gero Puhl; Jean-Nicolas Vauthey; Peter Neuhaus; Lorenzo Capussotti; Johann Pratschke; Sven-Christian Schmidt
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

3.  Validation of the estimation of physiologic ability and surgical stress (E-PASS) score in liver surgery.

Authors:  Vanessa M Banz; Peter Studer; Daniel Inderbitzin; Daniel Candinas
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

4.  Peri-operative morbidity affects the long-term survival in patients following liver resection for colorectal metastases.

Authors:  Mettu S Reddy; Shahid Farid; Rajendra Prasad
Journal:  J Gastrointest Surg       Date:  2008-11-11       Impact factor: 3.452

5.  Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

6.  Effects of postoperative morbidity on long-term outcome following surgery for colorectal liver metastases.

Authors:  T M Lodewick; M C de Jong; R M van Dam; M H A Bemelmans; U P Neumann; S W M Olde Damink; C H C Dejong
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

7.  Surgical salvage of recurrence after resection of colorectal liver metastases: incidence and outcomes.

Authors:  Nuh N Rahbari; Michael I D'Angelica
Journal:  Hepat Oncol       Date:  2017-08-03

8.  Pleural Effusion After Hepatectomy for Hepatocellular Carcinoma: Risk Factor Analyses and Its Impact on Oncological Outcomes.

Authors:  Hideaki Uchiyama; Norifumi Harimoto; Shinji Itoh; Tomoharu Yoshizumi; Toru Ikegami; Yoshihiko Maehara
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

9.  Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP.

Authors:  Mathias Worni; Christopher R Mantyh; Igor Akushevich; Ricardo Pietrobon; Bryan M Clary
Journal:  J Gastrointest Surg       Date:  2012-09-13       Impact factor: 3.452

10.  Long-term quality of life after hepatic resection: health is not simply the absence of disease.

Authors:  Vanessa M Banz; Daniel Inderbitzin; Regula Fankhauser; Peter Studer; Daniel Candinas
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.